Efficacy and Safety of Belimumab Plus Standard Therapy in Patients With Systemic Lupus Erythematosus: A Meta-analysis

Abstract Purpose The treatment of belimumab plus standard therapy in patients with systemic lupus erythematosus (SLE) has been studied extensively in recent years. Our aim was to estimate the efficacy and safety of this therapy compared with placebo plus standard therapy in patients with SLE. Method...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical therapeutics 2016-05, Vol.38 (5), p.1134-1140
Hauptverfasser:	Wei, Li-qiang, MS, Liang, Yong-gang, BS, Zhao, Yong, MS, Liang, Hui-tao, BS, Qin, Dong-chun, MS, She, Ming-cong, MS
Format:	Artikel
Sprache:	eng
Schlagworte:	adverse event Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use belimumab Bias Clinical trials Ethnicity Hispanic Americans Humans Immunoglobulins Internal Medicine Lupus Lupus Erythematosus, Systemic - drug therapy Medical Education Meta-analysis Patients Quality Randomized Controlled Trials as Topic Rheumatology Sensitivity analysis Studies systemic lupus erythematosus Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!